American Society of Clinical Oncology Educational Book
Overview
The American Society of Clinical Oncology Educational Book is a reputable journal that serves as a comprehensive resource for healthcare professionals in the field of oncology. It features insightful articles, reviews, and case studies, providing up-to-date information on the latest advancements in cancer research, treatment modalities, and patient care. This educational book is a valuable tool for oncologists, researchers, and students seeking to enhance their knowledge and improve clinical practice in the ever-evolving field of oncology.
Details
Details
Abbr.
Am Soc Clin Oncol Educ Book
Start
1900s
End
Continuing
Frequency
Annual
p-ISSN
1548-8748
e-ISSN
1548-8756
Country
United States
Language
English
Specialty
Oncology
Metrics
Metrics
h-index / Ranks: 6577
56
SJR / Ranks: 2041
1464
Recent Articles
1.
Filon M, Schmidt B
Am Soc Clin Oncol Educ Book
. 2025 Feb;
45(2):e471942.
PMID: 39933135
Non-muscle-invasive bladder cancer (NMIBC) comprises 75% of newly diagnosed bladder cancer and poses significant clinical challenges because of high recurrence and progression rates. Despite the effectiveness of Bacillus Calmette-Guérin (BCG)...
2.
Zarrabi K, Saxena A, Mouw K, Koshkin V, Friedlander T
Am Soc Clin Oncol Educ Book
. 2025 Feb;
45(2):e471924.
PMID: 39913872
Antibody-drug conjugates (ADCs) represent an emerging class of therapeutics across solid tumor oncology and are already positioned as a cornerstone therapy for patients with urothelial carcinoma (UC). In recent years,...
3.
Bellmunt J, Russell B, Szabados B, Valderrama B, Nadal R
Am Soc Clin Oncol Educ Book
. 2025 Jan;
45(2):e471912.
PMID: 39883890
The growing sophistication of tumor molecular profiling has helped to slowly transition oncologic care toward a more personalized approach in different tumor types, including in bladder cancer. The National Comprehensive...
4.
Nakayama I, Shitara K
Am Soc Clin Oncol Educ Book
. 2025 Jan;
45(1):e471716.
PMID: 39841955
Cell-based therapies have become integral to the routine clinical management of hematologic malignancies. Tumor-infiltrating lymphocyte (TIL) therapy has demonstrated efficacy in immunogenic solid tumors, such as melanoma. However, in the...
5.
Atreya C, Leach H, Asiimwe E, Bahri N, Le B, Macaire G, et al.
Am Soc Clin Oncol Educ Book
. 2025 Jan;
45(1):e471734.
PMID: 39841946
Data have matured to support incorporation of integrative oncology modalities into comprehensive cancer care. Clinical practice guidelines have recently been published by ASCO for diet and exercise (2022) and use...
6.
7.
Au-Yeung G, MacArthur E, Chan J, Ilenkovan N, Frumovitz M, Fader A, et al.
Am Soc Clin Oncol Educ Book
. 2024 Aug;
44(3):e431818.
PMID: 39177646
In the field of gynecologic cancer, low-grade serous ovarian cancer (LGSOC) has been poorly understood and underinvestigated until recently. Similarly, understanding of the distinct properties and therapeutic sensitivities of gynecologic...
8.
Sedhom R, Bates-Pappas G, Feldman J, Elk R, Gupta A, Fisch M, et al.
Am Soc Clin Oncol Educ Book
. 2024 Aug;
44(3):e434026.
PMID: 39177644
Communication in oncology has always been challenging. The new era of precision oncology creates prognostic uncertainty. Still, person-centered care requires attention to people and their care needs. Living with cancer...
9.
Dow L, Kapo J, Boyle F, Shin J
Am Soc Clin Oncol Educ Book
. 2024 Jul;
44(3):e432554.
PMID: 39018514
Palliative care is a comprehensive approach aimed at enhancing the quality of life of patients and their families living with serious illnesses such as breast cancer. This approach includes assessing...
10.
Negbenebor N
Am Soc Clin Oncol Educ Book
. 2024 Jul;
44(3):e433376.
PMID: 39013125
Skin cancer is the most common type of cancer affecting people in America. Skin cancer grows in patients from many diverse racial and ethnic backgrounds. Research shows that there are...